Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
F. Wolfe, K. Ross, J. Anderson, I.L. Russell, L. Hebert.
The prevalence and characteristics of fibromyalgia in the general population.
Arthritis Rheum, 38 (1995), pp. 19-28
[2.]
E. Robles Gómez.
Fibromialgia. Intoducción, conceptos y fisiopatología.
Encuentros médicos, (1995), pp. 4-10
[3.]
F. Wolfe.
Fibromyalgia: the clinical syndrom.
Rheum Dis Clin NA, 15 (1989), pp. 1-12
[5.]
L.A. Bradley, L.D. Young, K.O. Anderson, R.A. Turner, C.A. Agudelo, L.K. McDaniel, et al.
Effects of psychological therapy on pain behavior of rheumatoid arthritis patients. Treatment outcome and sixmonth followup.
Arthritis Rheum, 30 (1987), pp. 1105-1114
[6.]
J.W.S. Vlaeyen, N.J.G. Teeken-Gruben, M.E.J.B. Goossens, M.P.M.H. Rutten-van Mölken, R.A.G.B. Pelt, H. Van Eek, et al.
Cognitive-educational treatment of fibromyalgia: a randomized clinical trial: I. Clinical effects.
J. Rheumatol, 23 (1996), pp. 1237-1245
[7.]
S.P. Buckelew, R. Conway, J. Parker, W.E. Deuser, J. Jennings, T.E. Witty.
Biofeedback/ relaxation training and exercise interventions for fibromyalgia: a prospective trial.
Arthritis Care Res, 11 (1998), pp. 196-209
[8.]
G.A. McCain, D.A. Bell, F.M. Mai, P.D. Halliday.
A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia.
Arthritis Rheum, 31 (1988), pp. 1135-1141
[9.]
L. Martin, S.M. Edwothy, B. Macintosh.
Is exercise hepful in treatment of fibromyalgia?.
Arthritis Rheum, 36 (1993), pp. 292
[10.]
B. Jaeger, S.A. Skootsky.
Double-blind controlled study of differente myofascial trigger point injection techniques.
Pain, 31 (1987), pp. 292
[11.]
W.S. Wike.
Treatment o f reisitant fibromyalgia.
Rheum Clin Dis North Am, 21 (1995), pp. 247-260
[12.]
M.D. Rothenberg.
New pain killwer may have special benefits for the treatment of fibromyalgia.
Fibromyalgia Frontiers, 3 (1995), pp. 5-6
[13.]
I.J. Rusell, E.M. Fltcher, J.E. Michalek, P.C. Mc Broom, G.G. Hester.
Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam: doubleblind, pacebo-controlled study.
Arthritis Rheum, 34 (1991), pp. 552-560
[14.]
M.B. Yunus, A.T. Masi, J.C. Aldag.
Short term effects of ibuprofen in primary fibromyalgia syndrome: a double-blind, placebo controlled trial.
J Rheumatol, 16 (1989), pp. 527-532
[15.]
S. Clark, E. Tindall, R.M. Bennett.
A double-blind cross-over trial of prednisone versus placebo in the treatment of fibrositis.
J Rheumatol, 12 (1985), pp. 980-983
[16.]
R.A. Scudds, G.A. McCain, M. Rollman Gb y Harth.
Improvement in pain responsiveness in patients with fibrositis after succesfull treatmente with amitriptyline.
J Rheumatol, 16 (1989), pp. 98-103
[17.]
H. Moldofsky.
Sllep and fibrositis syndrome.
Rheum Dis Clin NA, 15 (1989), pp. 90-103
[18.]
S. Carette, M.J. Bell, W.J. Reynolds, B. Haraoui, G.A. McCain, V.P. Bykerk, et al.
Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: a randomized, doebleblind clinical trial.
Arthritis Rheum, 37 (1994), pp. 32-40
[19.]
F. Wolfe, J. Anderson, D. Harkness, R.M. Bennett, X.J. Caro, D.L. Goldenberg, et al.
A prospective, longitudional, multicenter study of service utilization and costs in fibromyalgia (see comments).
Arthritis Rheum, 40 (1997), pp. 1560-1570
[20.]
V. Fossaluza, S. De Vita.
Combined therapy with cyclobenzaprine and ibuprofen in primary fibromyalgia syndrome.
Int J Clin Pharmacol Res, 12 (1992), pp. 99-102
[21.]
R.M. Bennett, R.A. Gatter, S.M. Campbell, R.P. Andrews, S.R. Clark, J.A. Scarola.
A comparison of cyclobenzaprine and placebo in the manegement of fibrositis. A double-blind controlled study.
Arthritis Rheum, 31 (1988), pp. 1535-1542
[22.]
F. Wolfe, M.A. Cathey, D.J. Hawley.
A double-blind placebo controlled trial of fluoxetine in fibromyalgia.
Scand J Rheumatol, 23 (1994), pp. 255-259
[23.]
F. Cantini, BelllandiF, L. Niccoli, O. Di Munno.
Fluoxetin combined with cyclobenzaprine in the treatment of fibromyalgia (in Italian).
Minerva Medica, 85 (1994), pp. 97-100
[24.]
D.L. Goldenberg, M. Mavssky, C. Mossey.
The independent and combined efficacy of fluoxetine and amitrityline in the treatment of fibromyalgia.
Arthritis Rheum, 38 (1995), pp. 229
[25.]
A.J. Wysenbeek, F. Mor, Y. Lurie, A. Weinberger.
A imipramine for the treatment of fibrositis. A therapeutic trial.
Am Rheum Dis, 44 (1985), pp. 752-753
[26.]
J.Q. Carrera, A.V. Castano, J.P. Gómez, A.F. Rodríguez, W.H. Medano, A.G. Rubeio, et al.
Comparison of tenoxican and bromazepam in the treatment of fibromyalgia: a randomized, double-blind, placebo controlled trial.
Pain, 65 (1996), pp. 221-225
[27.]
D.T. Felson, D.L. Goldenberg.
The natural history of fibromyalgia.
Arthritis Rheum, 29 (1986), pp. 1522-1526
[28.]
F. Wolfe, D.J. Hawley, M.A. Cathey, X. Caro, I.J. Russell.
Fibrositis: symptom frecuency and criteria for diagnosis. An evaluation of 291 rheumatic disease patients and 58 normal individuals.
J Rheumatol, 12 (1985), pp. 1159-1163
[29.]
J.L. Andreu Sánchez, P. Barceló García, M. Figueras Pedrosa.
Fibromialgia. Otros reumatismos asociados a trastornos psicógenos. Manual de enfermedades reumáticas de la Sociedad Española de Reumatología.
pp. 757-764
[30.]
S. Graciela, L.A. Braley.
Advances in the treatment of fibromyalgia: current status and future directions.
Am J Med Scien, 315 (1998), pp. 397-404
Copyright © 2000. Elsevier España, S.L.. Todos los derechos reservados
